Tags : ARVO

Biosimilars

Samsung Bioepis Presents Results of SB11 (proposed biosimilar ranibizumab) at

Shots: The company reported the results from a study based on the structural and functional analysis of SB11, a proposed biosimilar referencing Lucentis (ranibizumab) The analytical assessment demonstrated that structural, physicochemical characterization i.e. amino acid sequence, post-translational modifications, higher order structure, and size and charge variants of SB11 were similar to Lucentis The SB11 is […]Read More